Neurophysiologic Correlates of Hypersomnia
1 other identifier
observational
76
1 country
1
Brief Summary
The goal of this project is to examine the neurophysiology of hypersomnia during sleep and wakefulness, to identify biomarkers for excessive sleepiness in neuropsychiatric disorders, and pilot acoustical slow wave induction during sleep in patients with hypersomnolence, to determine if this decreases daytime sleepiness in these patients. The primary study hypotheses are that individuals with hypersomnolence will have reduced slow wave activity (SWA) during sleep and increased waking theta/alpha activity during wake in specific brain regions. A secondary hypothesis is that acoustical slow wave induction in hypersomnolent patients will increase SWA during sleep, reduce theta/alpha activity during wake, and improve subjective sleepiness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2012
CompletedFirst Posted
Study publicly available on registry
November 1, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedDecember 24, 2018
December 1, 2018
5.6 years
October 24, 2012
December 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Nocturnal Slow Wave Activity
EEG recordings during sleep will be analyzed to assess slow wave activity in the 1-4.5Hz range.
Individual nights of sleep recorded within an average of 4 weeks of enrollment
Secondary Outcomes (1)
Waking theta/alpha activity
Individual days of waking EEG will be recorded within an average of 4 weeks of enrollment
Study Arms (8)
MDD with Hypersomnia
Participants with Major Depressive Disorder and co-morbid hypersomnia
MDD without hypersomnia
Participants with Major Depressive Disorder but without co-morbid hypersomnia
BPAD with hypersomnia
Participants with Bipolar Affective Disorder and co-morbid hypersomnia
BPAD without hypersomnia
Participants with Bipolar Affective Disorder without co-morbid hypersomnia
Primary Hypersomnia
Patients with primary hypersomnia (idiopathic hypersomnia)
Primary Insomnia
Patients with primary insomnia
Narcolepsy
Subjects with narcolepsy
Healthy Controls
healthy participants
Interventions
Brief tones (50 millisecond duration) at a frequency of 0.8 and 2 Hz, a rate that approximates the natural cellular oscillations of cortical neurons during sleep, will be played in blocks of 15-20 during non-rapid eye movement (NREM) sleep. Blocks of active acoustic slow wave induction will be followed by blocks of equal duration without induction, in order to make comparisons between stimulation periods (ON) and no stimulation periods (OFF). Tone intensity will be manually adjusted so as to be above an individual participant's auditory threshold during waking, but still quiet enough as not to awaken the subject from sleep. Sham slow wave induction will consist of auditory tones played prior to sleep, and during sleep of insufficient timing and intensity to alter slow wave activity.
Eligibility Criteria
Subjects will be recruited from the greater Madison, WI area. Hypersomnolent subject groups (n=30 in each group) may include unipolar MDD with hypersomnolence, primary hypersomnia (idiopathic hypersomnia), bipolar disorder with hypersomnolence, and narcolepsy. Non-hypersomnolent comparison groups (n=30 in each group) will include: MDD without hypersomnolence, bipolar disorder without hypersomnolence, primary insomnia, and healthy controls.
You may qualify if:
- Meet Diagnostic and Statistical Manual edition IV criteria for neuropsychiatric disorders enumerated in study population description
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin-Madison, Department of Psychiatry
Madison, Wisconsin, 53719, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David T Plante
University of Wisconsin, Madison
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2012
First Posted
November 1, 2012
Study Start
November 1, 2012
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
December 24, 2018
Record last verified: 2018-12